FDA Approves Extended-Release Lamotrigine for Treatment of Epilepsy
Links shared publicly online about this topic.
- 1,996total visits
FDA Approves Extended-Release Lamotrigine for Treatment of Epilepsy
View full resource at urlborg.com
Tags: Seizure, Seizure Medication, Epilepsy, FDA, Lamictal, Epilepsy Medication
Most Recently Shared on June 3, 2009 at 10:38 pm By:
FDA Approves Extended-Release Lamotrigine for Adjunctive Treatment of Epilepsy: The FDA has approved Lamictal as.. http://ub0.cc/5m/3p
FDA Approves Lamictal®XR™ (Lamotrigine) For Conversion To Monotherapy For Treatment Of Partial Seizures In Appropriate Patients
medicalnewstoday.com — “GlaxoSmithKline (GSK) announced that the U.S. Food and Drug Administration (FDA) has approved Lamictal® XR™ (lamotrigine) Extended-Release Tablets for conversion to monotherapy in patien” View full resource at medicalnewstoday.com
Most Recently Shared on April 28, 2011 at 1:11 am By:
Danielle M.Rocheford Patient Expert
FDA Approves Lamictal®XR™ (Lamotrigine) For Conversion To Monotherapy For Treatment Of Partial Seizures In Appro... http://bit.ly/jj6RYo
FDA Approves Lamictal®XR™ (Lamotrigine) For Conversion To Monotherapy For Treatment Of Partial Seizures In Appropriate Patients
medicalnewstoday.com — “GlaxoSmithKline (GSK) announced that the U.S. Food and Drug Administration (FDA) has approved Lamictal® XR™ (lamotrigine) Extended-Release Tablets for conversion to monotherapy in patien” View full resource at medicalnewstoday.com
Most Recently Shared on April 27, 2011 at 8:05 am By:
MNT Clinical Trials Health News
FDA Approves Lamictal®XR™ (Lamotrigine) For Conversion To Monotherapy For Treatment Of Partial Seizures In A... http://mnt.to/3V4D
GlaxoSmithKline, XenoPort receive FDA approval for Horizant to treat RLS
news-medical.net — “On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome.” View full resource at news-medical.net
Most Recently Shared on April 8, 2011 at 8:27 am By:
Epilepsy News: GlaxoSmithKline, XenoPort receive FDA approval for Horizant to treat RLS: On April 6, the U.S. Fo... http://bit.ly/g6qRcu
FDA Warns of Aseptic Meningitis Risk With Lamotrigine - QualityPoint Technologies
qualitypointtech.net — “FDA is warning that lamotrigine (Lamictal, GlaxoSmithKline), approved for treatment of epilepsy and bipolar disorder, can cause aseptic meningitis. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on August 12, 2010 at 11:21 pm By:
FDA Warns of Aseptic Meningitis Risk With Lamotrigine: FDA is warning that lamotrigine (Lamictal, GlaxoSmithKline)... http://bit.ly/aaxHqQ
Lamictal XR approved as add-on therapy for primary generalized tonic-clonic seizures - MPR
empr.com — “The FDA has approved Lamictal XR (lamotrigine extended-release tablets, from GlaxoSmithKline) as a once daily, add-on therapy for epilepsy in patients 13 years of age with primary generalized tonic-clonic seizures.” View full resource at empr.com
Most Recently Shared on February 1, 2010 at 4:03 pm By:
MPR News: Lamictal XR approved as add-on therapy for primary generalized tonic-clonic seizures: The FDA has approv... http://bit.ly/dnZGLd
GlaxoSmithKline's Lamictal XR Extended-Release Tablets receive FDA approval
news-medical.net — “laxoSmithKline announced today that the U.S. Food and Drug Administration has approved Lamictal®XR" (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 years and older with primary generalized tonic-clonic seizures.” View full resource at news-medical.net
Most Recently Shared on January 30, 2010 at 6:11 am By:
Epilepsy News: GlaxoSmithKline's Lamictal XR Extended-Release Tablets receive FDA approval: laxoSmithKline announc... http://bit.ly/bunP6F
Advertisement
